Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
weiwei发布了新的文献求助10
1秒前
1秒前
传奇3应助Yyyyy采纳,获得10
1秒前
2秒前
付艳发布了新的文献求助10
2秒前
Esmayil发布了新的文献求助10
2秒前
蒋若风发布了新的文献求助10
2秒前
棒棒完成签到,获得积分10
3秒前
3秒前
一一应助wzb采纳,获得10
3秒前
3秒前
冰美式发布了新的文献求助10
3秒前
HYN完成签到,获得积分10
3秒前
ding应助sfy66666采纳,获得10
3秒前
Romani完成签到,获得积分10
4秒前
斯文败类应助稳重的雁枫采纳,获得10
4秒前
Alan发布了新的文献求助20
4秒前
蓓蓓完成签到 ,获得积分10
5秒前
5秒前
koi发布了新的文献求助10
5秒前
6秒前
6秒前
HHD发布了新的文献求助10
6秒前
llhy发布了新的文献求助10
6秒前
6秒前
一一发布了新的文献求助20
7秒前
所所应助无限的山槐采纳,获得10
7秒前
7秒前
pupu完成签到,获得积分10
7秒前
开开心心完成签到,获得积分10
7秒前
所所应助邱丘邱采纳,获得10
8秒前
9秒前
tuyfytjt发布了新的文献求助10
9秒前
Romani发布了新的文献求助10
9秒前
肖肖完成签到,获得积分10
10秒前
卡卡完成签到,获得积分10
10秒前
妮妮发布了新的文献求助10
10秒前
10秒前
11秒前
Yyyyy发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Navigating Normative Orders. Interdisciplinary Perspectives 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7763335
求助须知:如何正确求助?哪些是违规求助? 9307868
关于积分的说明 20302760
捐赠科研通 7348209
什么是DOI,文献DOI怎么找? 3313962
关于科研通互助平台的介绍 2463728
邀请新用户注册赠送积分活动 2328148